IMRX - Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.